Ophthalmic-device company Presbia has received medical device registration approval in Israel for its Flexivue Microlens solution for treating presbyopia.
The treatment involves implanting a 3mm lens with an edge thickness of approximately 15µminto the corneal stroma of the patient’s non-dominant eye.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
To date, more than 500 patients have received the Flexivue Microlens and have reported a satisfaction rate of more than 90%, on average, the company said.
The Flexivue Microlens solution uses standard equipment and requires minimal additional training.
